Compare Vaxcyte Inc. Common Stock (PCVX) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Zillow Group Inc Class A — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.63B), while Zillow Group Inc Class A trades at $29.49 (market cap $6.42B). The key difference: Vaxcyte Inc. Common Stock is the larger of the two by market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Zillow Group Inc Class A nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Zillow Group Inc Class A for 86 Days on average.
| PCVX | ZG | |
|---|---|---|
Market Cap | $10.63B | $6.42B |
Volume | 1,525,205 | 1,301,685 |
Sector | Health | Media |
52-Week High | $73.82 | $74.58 |
52-Week Low | $40.32 | $27.70 |
Typical Hold Time | 0 Days | 86 Days |
Enterprise Value | $9.26B | $6.29B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zillow Group (ZG) trades at $28.85, up 0.56% on the day, amid a bearish technical signal but with improving fundamentals. The company reported a return to profitability in 2025 with net income of $23 million (source: company earnings, 2025), and revenue growth is projected to continue. Recent news highlights AI integration in real estate and shifting housing market dynamics. Analyst consensus is a 'Hold' with a $48.60 price target, suggesting significant potential upside from current levels.
The outlook is cautiously optimistic. The primary opportunity lies in the substantial gap between the current price and the analyst target, coupled with revenue growth and a strategic pivot. Key risks include persistent housing market affordability headwinds, competitive pressures, and the stock's high P/E ratio of 127.3, which demands sustained earnings growth to justify.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
